HENRY J. FUCHS - 13 Sep 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
President, Worldwide R&D
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
13 Sep 2024
Transactions value $
-$1,006,526
Form type
4
Filing time
17 Sep 2024, 17:54:07 UTC
Previous filing
19 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $20.6K +300 +0.15% $68.65 197K 30 Apr 2024 Direct F1
transaction BMRN Common Stock Tax liability -$1.03M -12.1K -6.14% $84.90 185K 13 Sep 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.